Assyro AI

FDA Orange Book · active-ingredient family

Dipyridamole

Dipyridamole is approved as 2 brand and 22 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:IV PERSANTINE · NDA 019817

2

Brand (NDA)

22

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable, tablet

ProductApplicantApplicationTEApproved
IV PERSANTINERLDBOEHRINGER INGELHEIMNDA 019817Dec 13, 1990
PERSANTINERLD×3BOEHRINGER INGELHEIMNDA 012836Dec 22, 1986

Generic (ANDA) products (22)

ProductApplicantApplicationTEApproved
DIPYRIDAMOLE×3CHARTWELL RXANDA 040898Apr 23, 2008
DIPYRIDAMOLE×3ZYDUS PHARMS USA INCANDA 040874ABJan 28, 2008
DIPYRIDAMOLE×3IMPAX LABSANDA 040782ABJul 18, 2007
DIPYRIDAMOLE×3RISINGANDA 040733ABFeb 13, 2007
DIPYRIDAMOLE×3OXFORD PHARMSANDA 040542ABApr 21, 2006
DIPYRIDAMOLEEUGIA PHARMA SPECLTSANDA 075769Nov 27, 2002
DIPYRIDAMOLEFRESENIUS KABI USAANDA 074956Sep 30, 1998
DIPYRIDAMOLECHARTWELL INJECTABLEANDA 074939APApr 13, 1998
DIPYRIDAMOLEHOSPIRAANDA 074601Dec 19, 1997
DIPYRIDAMOLEDR REDDYSANDA 074952Nov 26, 1997
DIPYRIDAMOLEHIKMAANDA 074521APOct 18, 1996
DIPYRIDAMOLEWATSON LABSANDA 087160Jun 07, 1996
DIPYRIDAMOLE×3ANI PHARMSANDA 086944Apr 16, 1991
DIPYRIDAMOLEGLENMARK GENERICSANDA 088999Feb 05, 1991
DIPYRIDAMOLEGLENMARK GENERICSANDA 089000Feb 05, 1991
DIPYRIDAMOLEGLENMARK GENERICSANDA 089001Feb 05, 1991
DIPYRIDAMOLEBARRANDA 087184ABOct 03, 1990
DIPYRIDAMOLEBARRANDA 087716ABOct 03, 1990
DIPYRIDAMOLEBARR LABSANDA 087717ABOct 03, 1990
DIPYRIDAMOLEPUREPAC PHARMANDA 089425Jul 12, 1990
DIPYRIDAMOLEPUREPAC PHARMANDA 089426Jul 12, 1990
DIPYRIDAMOLEPUREPAC PHARMANDA 089427Jul 12, 1990

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Dipyridamole — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.